SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-027708
Filing Date
2014-04-15
Accepted
2014-04-15 20:41:02
Documents
1
Period of Report
2014-04-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 22505
  Complete submission text file 0001209191-14-027708.txt   24875
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Reporting) CIK: 0000059478 (see all company filings)

State of Incorp.: IN | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36395 | Film No.: 14766312
SIC: 2834 Pharmaceutical Preparations

Mailing Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139
Business Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139 617-551-9600
Cerulean Pharma Inc. (Issuer) CIK: 0001401914 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 115 W WASHINGTON STREET SUITE 1680 SOUTH INDIANAPOLIS IN 46204
Business Address 115 W WASHINGTON STREET SUITE 1680 SOUTH INDIANAPOLIS IN 46204 (317) 429-0140
Lilly Ventures Fund I LLC (Reporting) CIK: 0001575852 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36395 | Film No.: 14766311